Molecular Testing

  •  

    Cancer Commons Adapts to Remain True to Our Mission

    With: Shelley Frisbie

    People facing advanced cancer come to Cancer Commons to ensure they have all the information they need to make their best-possible cancer care decisions. Here, Curious Dr. George asks our CFO & COO Shelley Frisbie about recent updates to our organization. Curious Dr. George: You have been the CFO of Cancer Commons for some time and recently added the COO title and duties to… Read more »

  •   George Lundberg, MD

    Molecular testing often guides choices of immunotherapy, as illustrated in this OncLive story about endometrial cancer.

    .

  •   George Lundberg, MD

    Each person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.

    .

  •   George Lundberg, MD

    In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

    .

    .

  •  

    More Information from Less Tissue: Strata Oncology Excels

    With: Scott A. Tomlins, MD, PhDLaura E. Lamb, PhD

    For a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its weakest link. In the “brain-to-brain” concept of… Read more »

  •   Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about eReach, a study investigating whether telehealth can provide improved access to genetic testing for people at risk for cancer.

    .

  •   Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about how the cost, access, accuracy, privacy and other aspects of at-home genetic testing compare to medical genetic testing with a specialist. 

    .

  •   Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Results from the Know Your Tumor program shows overall survival benefit for patients with an actionable alteration and who received a matched therapy, compared to those with an actionable alteration and who did not receive a matched therapy. 

    .

  •   Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about Precision Promise, an adaptive multi-site clinical trial spearheaded by the Pancreatic Cancer Action Network.

    .

  •   Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: A new clinical trial is using precision medicine to identify the best individualized standard-of-care options for pancreatic cancer patients.

    .